SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-010456
Filing Date
2018-05-21
Accepted
2018-05-21 17:07:42
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20180331_10q.htm 10-Q 500276
2 EXHIBIT 31.1 ex_113484.htm EX-31.1 7999
3 EXHIBIT 31.2 ex_113485.htm EX-31.2 8237
4 EXHIBIT 32.1 ex_113486.htm EX-32.1 5149
  Complete submission text file 0001437749-18-010456.txt   2954134

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wint-20180331.xml EX-101.INS 463094
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20180331.xsd EX-101.SCH 40281
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20180331_cal.xml EX-101.CAL 23375
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20180331_def.xml EX-101.DEF 284522
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20180331_lab.xml EX-101.LAB 236128
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20180331_pre.xml EX-101.PRE 296159
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26422 | Film No.: 18850425
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1